Status:
COMPLETED
OCTA and Retinal Angiomatous Proliferation
Lead Sponsor:
Federico II University
Conditions:
Age Related Macular Degeneration
Eligibility:
All Genders
65-80 years
Brief Summary
To investigate, using optical coherence tomography angiography, the retinal vascular features in patients affected by RAP.
Detailed Description
Retinal vascular anomalous complex represents a distinct form of neovascularization in patients with age-related macular degeneration. The study investigated the changes in retinal vascular network u...
Eligibility Criteria
Inclusion
- age older than 65 years
- diagnosis of retinal angiomatous proliferation and reticular pseudodrusen
- absence of previous ocular surgery, congenital eye disease, high myopia (\>6 dioptres), actual or previous diagnosis of glaucoma, optic disc anomaly, macular or vitreoretinal diseases.
- absence of significant lens opacities, low-quality OCT-A images.
Exclusion
- age older than 80 years
- absence of diagnosis of retinal angiomatous proliferation and reticular pseudodrusen
- presence of previous ocular surgery, congenital eye disease, high myopia (\>6 dioptres), actual or previous diagnosis of glaucoma, optic disc anomaly, macular or vitreoretinal diseases.
- presence of significant lens opacities, low-quality OCT-A images.
Key Trial Info
Start Date :
September 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 20 2020
Estimated Enrollment :
118 Patients enrolled
Trial Details
Trial ID
NCT04689789
Start Date
September 1 2019
End Date
December 20 2020
Last Update
December 30 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Federico II University
Naples, Napoli, Italy, 80131